Peptides vs steroids: two different kinds of molecule.

Peptides are amino-acid chains and steroids are four-ring molecules, and they differ in structure, receptors, US legal status and sport rules.

Basics7 min read

Key takeaway

Peptides are not steroids. A peptide is a chain of amino acids joined by amide bonds, called peptide bonds. A steroid is a compound built on the four-ring cyclopenta[a]phenanthrene skeleton. Many peptide signals act on receptors at the cell surface, while steroid receptors classically work inside the cell as regulators of gene transcription. In the US, anabolic steroids are Schedule III controlled substances. Peptides have no class entry on the DEA’s controlled substances list. Some peptides are FDA-approved prescription drugs; research peptides sold for lab use are not approved drugs. WADA’s 2026 Prohibited List covers both groups, in separate sections.

At a glance

Article typeBasics
TopicPeptide science
Studies cited6
Related productsResearch peptide catalog

Peptides vs steroids is a chemistry question first. Peptides are chains of amino acids. Steroids are built on a fused four-ring carbon skeleton. The two classes differ in structure, in the kinds of receptors they act on, and in how US law and sport rules treat them.

Quick answer: Are peptides steroids? No. Peptides are amino-acid chains. Steroids are molecules built on a fused four-ring skeleton. They bind different kinds of receptors and sit in different legal categories. Anabolic steroids are Schedule III controlled substances under federal law. Most research peptides are not controlled substances, but they are not approved drugs either. In sport, the WADA Prohibited List bans both, under different sections.

What a peptide is

IUPAC, the body that sets chemical naming rules, defines a peptide as any compound produced by amide formation between a carboxyl group of one amino acid and an amino group of another. Those amide bonds are called peptide bonds. Chains of fewer than about 10 to 20 residues may be called oligopeptides, and longer ones polypeptides. Chains of more than about 50 residues are usually called proteins, though IUPAC notes that authors differ on where that line falls.

The order of the amino acids is the identity of a peptide. Octreotide, an FDA-approved prescription drug, is described on its label as a cyclic octapeptide: eight residues closed into a ring. Our primer on what peptides are covers the class in more depth.

What a steroid is

IUPAC’s steroid nomenclature defines steroids as compounds possessing the skeleton of cyclopenta[a]phenanthrene, or a skeleton derived from it by bond scissions or ring expansions or contractions. That skeleton is four fused carbon rings, lettered A to D. There are no amino acids and no peptide bonds in it.

The steroid class is much wider than “steroids” in the sports sense. IUPAC’s list of steroid drug names includes hydrocortisone, a corticosteroid, and ethinylestradiol, a synthetic estrogen. Testosterone is a steroid too: the DEA lists it by its systematic name, 17β-hydroxyandrost-4-en-3-one. US law narrows the term for control purposes. Under 21 U.S.C. § 802(41), an anabolic steroid is any drug or hormonal substance chemically and pharmacologically related to testosterone, other than estrogens, progestins, corticosteroids and dehydroepiandrosterone.

Table 1

Peptides and steroids, side by side

Attribute Peptides Steroids
Structure Amino acids joined by amide (peptide) bonds Four fused carbon rings (cyclopenta[a]phenanthrene skeleton)
What defines one The sequence of residues The ring skeleton and the groups attached to it
Typical receptors Many act on cell-surface receptors, such as G protein-coupled receptors Classically, receptors inside the cell that regulate gene transcription; some act from pools outside the nucleus
Examples Octreotide (cyclic octapeptide) Testosterone, hydrocortisone
US controlled-substance status No class entry on the DEA list Anabolic steroids: Schedule III
WADA 2026 list S2 (peptide hormones, growth factors, related substances and mimetics); S0 for non-approved substances S1.1 (anabolic androgenic steroids)

How they act at the receptor level

In general terms, the two classes signal to cells in different ways. Many of the body’s own peptides activate G protein-coupled receptors (GPCRs), a family of cell-surface receptors. A 2020 review counted nearly 50 approved peptide drugs that target GPCRs.

Steroid receptors work differently. They belong to a superfamily of regulatory proteins that control gene transcription, a family that also includes the receptors for thyroid hormone and retinoic acid. The classic picture places them in the nucleus. A 2016 review adds that most steroid receptors also exist in pools outside the nucleus, including at the plasma membrane, where a steroid can set off rapid signals.

That is the general picture only. It describes how each class signals. It says nothing about what any particular compound does.

Anabolic steroids are federally controlled. The DEA’s alphabetical list of controlled substances (12 November 2026 edition) has a Schedule III entry for “anabolic steroids,” covering any substance that meets the definition in 21 CFR 1300.01. It also lists individual steroids, including testosterone and nandrolone, in Schedule III. The DEA’s schedules page describes Schedule III substances as having a potential for abuse less than Schedules I or II, with abuse that may lead to moderate or low physical dependence or high psychological dependence.

Peptides are not a scheduled class. The same DEA list has no class entry for peptides. That does not make research peptides approved drugs. The FDA’s drug center evaluates new drugs before they can be sold, and approval means the data on a drug’s effects have been reviewed. A vial sold as a laboratory reagent has not been through that review as a drug, even when it shares a name with an approved product.

Some peptides are approved medicines. A 2021 review counted more than 80 peptide drugs that have reached the market since insulin, and octreotide is one with a US prescription label. For the research side, see are peptides legal in the USA and research use only, explained.

Sport rules: WADA lists both

The World Anti-Doping Agency’s 2026 Prohibited List, in effect since 1 January 2026, covers both groups in its “prohibited at all times” section. Anabolic androgenic steroids sit in S1.1, under S1 Anabolic agents. Peptide hormones sit in S2, Peptide hormones, growth factors, related substances, and mimetics. Substances with no current approval by any government health authority for human therapeutic use fall under S0, Non-approved substances, which names BPC-157 as an example.

WADA’s anabolic class is not limited to steroids. S1.2, Other anabolic agents, lists non-steroid compounds such as clenbuterol and selective androgen receptor modulators. The S2 heading also covers other substances with a similar chemical structure or similar biological effect, so one section can hold very different molecules. Our guide to peptides on the 2026 WADA list goes through it section by section.

Why people ask whether peptides are steroids

The overlap is in context, not chemistry. Three overlaps stand out:

  • The same list. Both groups appear in the same “prohibited at all times” section of the WADA list.
  • Hormones of both kinds. The body makes signals of both types. Steroid hormones act through the steroid receptor family, and many of the body’s own peptides act through GPCRs.
  • The word “anabolic.” WADA’s anabolic agents class includes non-steroids, so “anabolic” and “steroid” are not the same word either.

The chemistry settles the question. By the IUPAC definitions, a peptide is an amino-acid chain and a steroid is a four-ring skeleton. A peptide is not a steroid.

Vitrapep Research Catalog

Lyophilized COA per lot Research use only

Research peptides supplied as laboratory reference compounds, each lot with a third-party certificate of analysis. For laboratory research use only, not for human or veterinary use.

View the catalog

Frequently asked questions

Are peptides steroids?

No. A peptide is a chain of amino acids joined by peptide bonds. A steroid is built on a four-ring cyclopenta[a]phenanthrene skeleton. The two classes share no core structure.

Is testosterone a peptide or a steroid?

A steroid. The DEA lists it as 17β-hydroxyandrost-4-en-3-one, in Schedule III.

Are peptides controlled substances?

Peptides are not a scheduled class, and the DEA list has no class entry for them. Research peptides are still not approved drugs. Approved peptide medicines, such as octreotide, are sold under their own FDA-approved labels.

Do peptides and steroids work the same way?

No. In general terms, many peptides act on receptors at the cell surface. Steroid receptors classically regulate gene transcription inside the cell, with some signaling from outside the nucleus.

Are peptides banned in sport?

Many are. The WADA 2026 list prohibits peptide hormones and growth factors under S2, and non-approved substances, such as BPC-157, under S0. Anabolic androgenic steroids are prohibited under S1.1.

What to know now

  • Different molecules: peptides are amino-acid chains; steroids are four-ring skeletons. A peptide is not a steroid.
  • Different receptors: many peptides act at cell-surface GPCRs; steroid receptors classically regulate transcription inside the cell.
  • Steroid is a wide word: it covers corticosteroids such as hydrocortisone and estrogens such as ethinylestradiol, as well as anabolic steroids.
  • US law: anabolic steroids are Schedule III. Peptides have no class entry on the DEA list.
  • Approval: some peptides are approved prescription drugs; research peptides sold for lab use are not approved drugs.
  • Sport: WADA bans both, under S1 (anabolic agents), S2 (peptide hormones) and S0 (non-approved substances).

What we’re watching

Both lists change. WADA updates the Prohibited List every year, and each edition takes effect on 1 January, so check the edition in force on the date that matters. The DEA’s alphabetical list of controlled substances also carries an edition date; the one cited here is dated 12 November 2026.

Also in the library

Sources: IUPAC-IUB Joint Commission on Biochemical Nomenclature 1984, Pure and Applied Chemistry; Moss 1989, Pure and Applied Chemistry; Novartis Pharmaceuticals Corporation. Octreotide acetate injection (prescribing information). DailyMed, Octreotide acetate injection; Davenport 2020, Nature Reviews Drug Discovery; Evans 1988, Science; Levin 2016, Nature Reviews Molecular Cell Biology; U.S. Drug Enforcement Administration 2026, Controlled Substances: Alphabetical Order; U.S. Drug Enforcement Administration, Controlled Substance Schedules; 21 U.S.C. § 802. Definitions. Legal Information Institute; U.S. Food and Drug Administration. Development & Approval Process: Drugs . https://www.fda.gov/drugs/development-approval-process-drugs, Development & Approval Process: Drugs; Muttenthaler 2021, Nature Reviews Drug Discovery; World Anti-Doping Agency 2025, World Anti-Doping Code International Standard: Prohibited List 2026. All 12 citations

Back to the research library

References

  1. IUPAC-IUB Joint Commission on Biochemical Nomenclature. (1984). Nomenclature and symbolism for amino acids and peptides (Recommendations 1983). Pure and Applied Chemistry, 56(5), 595–624. https://doi.org/10.1351/pac198456050595. Section 3AA-11, web version: https://iupac.qmul.ac.uk/AminoAcid/A1113.html
  2. Moss, G. P. (1989). Nomenclature of steroids (Recommendations 1989). Pure and Applied Chemistry, 61(10), 1783–1822. https://doi.org/10.1351/pac198961101783. Rule 3S-1.0, web version: https://iupac.qmul.ac.uk/steroid/3S01.html; INN appendix: https://iupac.qmul.ac.uk/steroid/3Sapp.html
  3. Novartis Pharmaceuticals Corporation. Octreotide acetate injection (prescribing information). DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e2c9856-1836-49f0-9472-4dbeeb408f39
  4. Davenport, A. P., Scully, C. C. G., de Graaf, C., Brown, A. J. H., & Maguire, J. J. (2020). Advances in therapeutic peptides targeting G protein-coupled receptors. Nature Reviews Drug Discovery, 19(6), 389–413. https://doi.org/10.1038/s41573-020-0062-z
  5. Evans, R. M. (1988). The steroid and thyroid hormone receptor superfamily. Science, 240(4854), 889–895. https://doi.org/10.1126/science.3283939
  6. Levin, E. R., & Hammes, S. R. (2016). Nuclear receptors outside the nucleus: Extranuclear signalling by steroid receptors. Nature Reviews Molecular Cell Biology, 17(12), 783–797. https://doi.org/10.1038/nrm.2016.122
  7. U.S. Drug Enforcement Administration, Diversion Control Division. (2026). Controlled Substances: Alphabetical Order (12 November 2026). https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf
  8. U.S. Drug Enforcement Administration, Diversion Control Division. Controlled Substance Schedules. https://www.deadiversion.usdoj.gov/schedules/schedules.html
  9. 21 U.S.C. § 802. Definitions. Legal Information Institute, Cornell Law School. https://www.law.cornell.edu/uscode/text/21/802
  10. U.S. Food and Drug Administration. Development & Approval Process: Drugs. https://www.fda.gov/drugs/development-approval-process-drugs
  11. Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021). Trends in peptide drug discovery. Nature Reviews Drug Discovery, 20(4), 309–325. https://doi.org/10.1038/s41573-020-00135-8
  12. World Anti-Doping Agency. (2025). World Anti-Doping Code International Standard: Prohibited List 2026 (in effect 1 January 2026). https://www.wada-ama.org/en/prohibited-list